Celon Pharma SA (CLNP)

Currency in PLN
15.44
-0.20(-1.28%)
Closed·
Advertisement
CLNP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.3215.96
52 wk Range
15.2023.50
Key Statistics
Bid/Ask
15.34 / 15.44
Prev. Close
15.64
Open
15.7
Day's Range
15.32-15.96
52 wk Range
15.2-23.5
Volume
19.48K
Average Volume (3m)
24.04K
1-Year Change
-25.9472%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLNP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.38
Upside
+31.99%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Celon Pharma SA News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
2 Hold
2 Sell
Ratings:
5 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 20.38
(+31.99% Upside)

Earnings

Latest Release
18/11/2026
EPS / Forecast
-- / --
Revenue / Forecast
63.2M / --
EPS Revisions
Last 90 days

Compare CLNP to Peers and Sector

Metrics to compare
CLNP
Peers
Sector
Relationship
P/E Ratio
8.3x8.7x−0.2x
PEG Ratio
-0.160.00
Price/Book
1.7x1.2x2.6x
Price / LTM Sales
3.3x0.7x2.6x
Upside (Analyst Target)
32.0%41.2%76.9%
Fair Value Upside
Unlock32.0%14.9%Unlock

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o.

Employees
560
Market
Poland

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.44M10.10%84.01M
Other Institutional Investors
38.44M71.37%593.49M
Public Companies & Retail Investors
9.98M18.53%154.05M
Total
53.86M100.00%831.54M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Glatton Sp. z o.o.55.75%30,027,531463,625
Tang Capital Partners, LP7.68%4,137,00063,875

People Also Watch

145.20
UNTP
-2.29%
151.00
DIAP
+1.48%
121.60
ABEP
-5.00%
58.25
ELT
-0.77%
300.00
SCW
-4.76%

FAQ

What Is the Celon Pharma (Warsaw: CLNP) Share Price Today?

The Celon Pharma stock price today is 15.44 PLN.

What Stock Exchange Does Celon Pharma (CLNP) Trade On?

Celon Pharma is listed and trades on the Warsaw Stock Exchange.

What Is the Ticker (Stock Symbol) for Celon Pharma?

The stock symbol (also called a 'ticker') for Celon Pharma is "CLNP."

What Is the Current Celon Pharma Market Capitalisation?

As of today, Celon Pharma (Warsaw: CLNP) market cap is 831.54M PLN.

Is CLNP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Celon Pharma moving averages and other technical indicators, the daily buy/sell signal for CLNP stock is Strong Sell.

How Many Times Has Celon Pharma Stock Split?

Celon Pharma has split 0 times. (See the CLNP stock split history page for full effective split date and price information.)

How Many Employees Does Celon Pharma Have?

Celon Pharma has 560 employees, based on their latest Companies House report.

What is the current trading status of Celon Pharma (Warsaw: CLNP)?

As of 21/11/2026, Celon Pharma (CLNP) is trading at a share price of 15.44 PLN, with a previous close of 15.64 PLN. The stock has fluctuated within a day range of 15.32 PLN to 15.96 PLN, while its 52-week range spans from 15.20 PLN to 23.50 PLN.

What Is Celon Pharma (CLNP) Price Target According to Analysts?

The average 12-month price target for Celon Pharma is 20.38 PLN, with a high estimate of 25.2 PLN and a low estimate of 16 PLN. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Sell. The stock has an +31.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.